A Decentralized Clinical Trial (DCT) is a study model that leverages technology and remote processes to conduct research outside traditional clinical settings. DCTs allow participants to engage in trials from their homes or local healthcare facilities, reducing the need for frequent visits to centralized study sites.
This approach utilizes digital health technologies, telemedicine, and home health care services to collect data and monitor participants. DCTs aim to improve patient recruitment and retention by offering greater convenience and accessibility, particularly for individuals with mobility issues or those living in remote areas.
Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by addressing key challenges in traditional trial methodologies. They offer potential solutions to issues such as slow patient recruitment, high dropout rates, and limited diversity in study populations, which have long hindered the efficiency and representativeness of clinical studies.
The importance of DCTs has been further highlighted by global events like the COVID-19 pandemic, which necessitated alternative approaches to conducting research. By embracing DCTs, the clinical research industry can enhance patient-centricity, improve data quality through continuous monitoring, and potentially accelerate the drug development process, leading to faster delivery of new treatments to patients.
Axcellant, a specialist global contract research organization (CRO), has been appointed by Switzerland-based Santersus AG to support the execution of…
Axcellant will participate in the Annual Congress of the European Association of Nuclear Medicine (EANM 2026), taking place from 17…
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
Copyright @ 2026 Axcellant|Privacy Policy|Cookie Policy|